GT197960869A -
N- (1-METHYL-2-PIRROLIDINYL METHYL) -2,3-DIMETOXI-5-METHYL SULFAMOIL-BENZAMIDE AND ITS DERIVATIVES, ITS PREPARATION METHODS AND ITS APPLICATION IN THE TREATMENT OF DISORDERS OF THE LOWER URINARY SYSTEM.
- Google Patents
N- (1-METHYL-2-PIRROLIDINYL METHYL) -2,3-DIMETOXI-5-METHYL SULFAMOIL-BENZAMIDE AND ITS DERIVATIVES, ITS PREPARATION METHODS AND ITS APPLICATION IN THE TREATMENT OF DISORDERS OF THE LOWER URINARY SYSTEM.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to GT197960869ApriorityCriticalpatent/GT197960869A/en
Publication of GT197960869ApublicationCriticalpatent/GT197960869A/en
SE REFIERE A UNA NUEVA VERATRAMIDA, LA N(1METIL2PIRROLIDINILMETIL)2,3DIMETOXI5METILSULFAMOILBENZAMIDA, SUS SALES DE ADICION DE ACIDOS FARMACOLOGICAMENTE ACEPTABLES, SUS SALES DE AMONIO CUATERNARIO, SU OXIDO Y SUS ISOMEROS LEVOGIRO Y DEXTROGIRO. ESTOS COMPUESTOS TIENEN LA ESTRUCTURA QUIMICA CONTENIDA EN LA FICHA TECNICA RESPECTIVA. SON PARTICULARMENTE ACTIVOS EN EL TRATAMIENTO DE TRASTORNOS DEL APARATO URINARIO INFERIOR.IT REFERS TO A NEW VERATRAMIDE, THE N (1METIL2PIRROLIDINILMETIL) 2,3DIMETOXI5METILSULFAMOILBENZAMIDA, ITS ADDITIONAL SALTS OF PHARMACOLOGICALLY ACCEPTABLE ACIDS, ITS SUBSTRATE LEVEL AND ITS YOGRO THESE COMPOUNDS HAVE THE CHEMICAL STRUCTURE CONTAINED IN THE RESPECTIVE TECHNICAL SHEET. THEY ARE PARTICULARLY ACTIVE IN THE TREATMENT OF DISORDERS OF THE LOWER URINARY SYSTEM.
GT197960869A1979-12-031979-12-03
N- (1-METHYL-2-PIRROLIDINYL METHYL) -2,3-DIMETOXI-5-METHYL SULFAMOIL-BENZAMIDE AND ITS DERIVATIVES, ITS PREPARATION METHODS AND ITS APPLICATION IN THE TREATMENT OF DISORDERS OF THE LOWER URINARY SYSTEM.
GT197960869A
(en)
N- (1-METHYL-2-PIRROLIDINYL METHYL) -2,3-DIMETOXI-5-METHYL SULFAMOIL-BENZAMIDE AND ITS DERIVATIVES, ITS PREPARATION METHODS AND ITS APPLICATION IN THE TREATMENT OF DISORDERS OF THE LOWER URINARY SYSTEM.
N- (1-METHYL-2-PIRROLIDINYL METHYL) -2,3-DIMETOXI-5-METHYL SULFAMOIL-BENZAMIDE AND ITS DERIVATIVES, ITS PREPARATION METHODS AND ITS APPLICATION IN THE TREATMENT OF DISORDERS OF THE LOWER URINARY SYSTEM.
N- (1-METHYL-2-PIRROLIDINYL METHYL) -2,3-DIMETOXI-5-METHYL SULFAMOIL-BENZAMIDE AND ITS DERIVATIVES, ITS PREPARATION METHODS AND ITS APPLICATION IN THE TREATMENT OF DISORDERS OF THE LOWER URINARY SYSTEM.
Process for producing polymorph b of n- (3-ethynylphenyl) -6,7-bis (2-methoxyethoxy) -4-quinazolinamine hydrochloride by recrystallization of n- (3-ethynylphenyl) -6,7-bis ( 2-methoxyethoxy) -4-quinazolinamine in a solvent containing ethanol and water (div. Sol. No. 3107-00).
PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS INCORPORATING AS ACTIVE INGREDIENT ISOXAZOL-4-CARBOXYLAMIDE AND HYDROXYLYLIDENE-CYANOOCETAMIDE
N- (1-METHYL-2-PIRROLIDINYL METHYL) -2,3-DIMETOXI-5-METHYL SULFAMOIL-BENZAMIDE AND ITS DERIVATIVES, ITS PREPARATION METHODS AND ITS APPLICATION IN THE TREATMENT OF DISORDERS OF THE LOWER URINARY SYSTEM.